Hiroshi Mikashima - Concepedia

Author

Hiroshi Mikashima

Kyoto Pharmaceutical Industries (Japan)

Also Known As

H. MIKASHIMA, H. Mikashima, HIROSHI MIKASHIMA, Hiroshi MIKASHIMA, Hiroshi Mikashima, Mikashima Hiroshi

Publications

184

Citations

H-Index

Concepts

All Affiliations

Kyoto Pharmaceutical Industries (Japan)

About

Hiroshi Mikashima is an author at Kyoto Pharmaceutical Industries (Japan) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	125
2	Neurology	2	2	60
3	Anesthesia	1	1	14
4	Biochemistry	1	1	23
5	Immunology	1	1	14

Hiroshi Mikashima

Publications

137

Citations

H-Index

Page 1

	Year	Citations
Pharmacological actions of Y-24180, a new specific antagonist of Platelet Activating Factor (PAF): II. Interactions with PAF and benzodiazepine receptors Shuzo Takehara, Hiroshi Mikashima, Yoshito Muramoto, Prostaglandins ThrombopoiesisMolecular PharmacologyThrombosisBlood PlateletMedicine	1990	43
Effects of γ-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function Hiroshi Mikashima, Hiroshi Ochi, Yoshito Muramoto, Thrombosis Research ThrombosisBiochemistryBlood PlateletMedicinePlatelet Function	1986	23
Y-590 (A new pyridazinone derivative), a potent anti-thrombotic agent — I. Effect on platelet function Hiroshi Mikashima, T Nakao, Kazuhiro Goto Thrombosis Research ThrombosisBlood PlateletPlatelet FunctionHematologyPharmacology	1983	17
Y-590 (A new pyridazinone derivative), a potent anti-thrombotic agent — II. Inhibition of platelet phosphodiesterase Hiroshi Mikashima, T Nakao, Kazuhiro Goto, Thrombosis Research Molecular PharmacologyMedicinal ChemistryThrombosisBlood PlateletMedicine	1984	17
Antagonistic activity of etizolam on platelet-activating factor. In vivo exeperiments. Michio Terasawa, Hiroshi Mikashima, Tetsuya Tahara, The Japanese Journal of Pharmacology ImmunologyPharmacotherapyReversed PafExperimental PharmacologyInflammation	1987	14
An antagonistic activity of etizolam on platelet-activating factor(PAF). In vitro effects on platelet aggregation and PAF receptor binding. Hiroshi Mikashima, Shuzo Takehara, Yoshito Muramoto, The Japanese Journal of Pharmacology	1987	12
PAF antagonistic activity of some thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepines. Tetsuya Tahara, Hiroshi Mikashima, Michio Terasawa, Chemical and Pharmaceutical Bulletin Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryRabbit PrpPharmacological Study	1987	11

Page 1